Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ACER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CLGN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPY30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KIF14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
YWHAQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIOK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDZD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGMS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAICS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LNPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WASF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASSF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on